z-logo
open-access-imgOpen Access
Doxapram Treatment and Diaphragmatic Activity in Preterm Infants
Author(s) -
Cornelia G. de Waal,
Gerard J. Hutten,
Juliette V. Kraaijenga,
Frans H. de Jongh,
Anton H. van Kaam
Publication year - 2018
Publication title -
neonatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.399
H-Index - 84
eISSN - 1661-7819
pISSN - 1661-7800
DOI - 10.1159/000493359
Subject(s) - doxapram , medicine , anesthesia , apnea , diaphragmatic breathing , endocrinology , pathology , alternative medicine
Doxapram is a treatment option for severe apnea of prematurity (AOP). However, the effect of doxapram on the diaphragm, the main respiratory muscle, is not known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom